CA Stock MarketDetailed Quotes
TMD Conavi Medical Corp
- 0.045
- 0.0000.00%
15min DelayMarket Closed Oct 15 16:00 ET
5.13MMarket Cap-661P/E (TTM)
0.000High0.000Low0Volume0.000Open0.045Pre Close0.00Turnover3.00052wk High0.00%Turnover Ratio114.04MShares1.12552wk Low-0.068EPS TTM5.11MFloat Cap2070.000Historical High0.56P/E (Static)113.58MShs Float1.125Historical Low0.08EPS LYR0.00%Amplitude--Dividend TTM0.05P/B1Lot Size--Div YieldTTM
Conavi Medical Corp Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -117.54%-1.66M | 10.44%-1.69M | 116.97%4.68M | 91.84%-645K | 72.44%-2.27M | 199.48%9.48M | 1.97%-1.89M | 24.69%-27.58M | 35.73%-7.9M | 19.97%-8.22M |
| Net income from continuing operations | -108.03%-1.07M | 68.61%-807K | 116.34%6.95M | 73.13%-3.24M | 95.28%-489K | 221.80%13.26M | 72.12%-2.57M | -186.32%-42.54M | -227.96%-12.07M | -21.22%-10.37M |
| Operating gains losses | ---- | ---- | 60.02%-1.82M | -139.29%-132K | -504.91%-1.36M | 95.28%-83K | 91.37%-251K | 70.92%-4.56M | 102.78%336K | 95.97%-224K |
| Depreciation and amortization | --0 | --0 | -78.35%186K | -70.61%87K | -84.58%33K | -83.42%32K | -78.21%34K | 22.89%859K | 0.00%296K | 27.38%214K |
| Asset impairment expenditure | ---- | ---- | -14.25%1.99M | ---- | ---- | ---- | ---- | --2.32M | ---- | ---- |
| Remuneration paid in stock | -99.04%6K | -207.95%-190K | -75.61%996K | -101.33%-26K | -82.02%224K | 110.85%622K | -70.32%176K | 1.16%4.08M | 368.51%1.95M | -12.38%1.25M |
| Deferred tax | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -200.00%-56K | ---- | ---- |
| Other non cashItems | 103.70%24K | -25.53%35K | -48.00%65K | -242.55%-67K | 1,645.24%733K | -3,700.00%-648K | 161.11%47K | 135.92%125K | 109.11%47K | -28.81%42K |
| Change In working capital | 83.03%-628K | -207.37%-728K | -130.22%-3.68M | 203.88%750K | -262.30%-1.41M | -241.98%-3.7M | -92.82%678K | 215.71%12.19M | 92.69%-722K | -60.20%870K |
| -Change in receivables | --16K | --15K | -101.22%-101K | --355K | ---456K | --0 | --0 | 182.57%8.28M | --0 | --0 |
| -Change in prepaid assets | -52.29%271K | -40.28%301K | -40.93%785K | -232.58%-822K | 162.94%535K | 74.23%568K | -59.12%504K | 183.22%1.33M | 145.12%620K | -518.72%-850K |
| -Change in payables and accrued expense | 65.90%-915K | -409.27%-1.04M | -329.63%-3.16M | 190.69%1.22M | -390.08%-1.49M | -217.68%-2.68M | -173.33%-205K | 26.56%1.38M | -187.77%-1.34M | -74.08%514K |
| -Change in other working capital | ---- | ---- | -200.00%-1.21M | --0 | --0 | ---1.59M | --379K | --1.21M | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -117.54%-1.66M | 10.44%-1.69M | 116.97%4.68M | 91.84%-645K | 72.44%-2.27M | 199.48%9.48M | 1.97%-1.89M | 24.69%-27.58M | 35.73%-7.9M | 19.97%-8.22M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 102.35%24K | -68.98%-561K | 410.00%682K | 86.33%-41K | 66.67%-56K | -35.10%-1.02M | -115.58%-332K | 17.29%-220K |
| Net PPE purchase and sale | ---- | ---- | 133.71%237K | --0 | ---- | ---- | ---- | -90.00%-703K | -518.92%-229K | 22.65%-140K |
| Net intangibles purchas and sale | --0 | --0 | 32.81%-213K | -444.66%-561K | 656.25%445K | 43.06%-41K | 9.68%-56K | 17.66%-317K | 11.97%-103K | 5.88%-80K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 102.35%24K | -68.98%-561K | 410.00%682K | 86.33%-41K | 66.67%-56K | -35.10%-1.02M | -115.58%-332K | 17.29%-220K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -73.81%-146K | -84.81%-146K | -7.64%-451K | -29.20%-146K | -40.59%-142K | 19.23%-84K | 21.78%-79K | -100.95%-419K | -244.87%-113K | -147.64%-101K |
| Net issuance payments of debt | -73.81%-146K | -84.81%-146K | -7.13%-451K | -29.20%-146K | -37.86%-142K | 19.23%-84K | 21.78%-79K | -1,375.76%-421K | -244.87%-113K | 11.97%-103K |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -99.98%2K | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -73.81%-146K | -84.81%-146K | -7.64%-451K | -29.20%-146K | -40.59%-142K | 19.23%-84K | 21.78%-79K | -100.95%-419K | -244.87%-113K | -147.64%-101K |
| Net cash flow | ||||||||||
| Beginning cash position | 350.43%5.71M | 129.34%7.54M | -89.82%3.29M | -23.56%8.9M | -47.37%10.62M | -95.79%1.27M | -89.82%3.29M | 26.84%32.31M | -73.96%11.64M | -63.31%20.18M |
| Current changes in cash | -119.34%-1.81M | 9.20%-1.84M | 114.66%4.25M | 83.80%-1.35M | 79.80%-1.73M | 194.17%9.35M | 7.84%-2.02M | -524.41%-29.02M | 32.53%-8.35M | 17.28%-8.54M |
| End cash Position | -63.30%3.9M | 350.43%5.71M | 129.34%7.54M | 129.34%7.54M | -23.56%8.9M | -47.37%10.62M | -95.79%1.27M | -89.82%3.29M | -89.82%3.29M | -73.96%11.64M |
| Free cash from | -117.62%-1.66M | 13.02%-1.69M | 115.62%4.47M | 91.43%-706K | 72.51%-2.32M | 196.02%9.44M | 7.17%-1.94M | 23.48%-28.6M | 33.86%-8.23M | 19.91%-8.44M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data